ATE132517T1 - Nichtporöse kollagenfolie zur therapeutischen verwendung, und verfahren und vorrichtung zu ihrer herstellung - Google Patents

Nichtporöse kollagenfolie zur therapeutischen verwendung, und verfahren und vorrichtung zu ihrer herstellung

Info

Publication number
ATE132517T1
ATE132517T1 AT92107249T AT92107249T ATE132517T1 AT E132517 T1 ATE132517 T1 AT E132517T1 AT 92107249 T AT92107249 T AT 92107249T AT 92107249 T AT92107249 T AT 92107249T AT E132517 T1 ATE132517 T1 AT E132517T1
Authority
AT
Austria
Prior art keywords
therapeutic use
producing same
collagen film
porous collagen
weight
Prior art date
Application number
AT92107249T
Other languages
English (en)
Inventor
Diego Furlan
Giovanni Bonfanti
Giuseppe Scappaticci
Original Assignee
Euroresearch Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroresearch Srl filed Critical Euroresearch Srl
Application granted granted Critical
Publication of ATE132517T1 publication Critical patent/ATE132517T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0031—Degasification of liquids by filtration
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof
    • C08J2389/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08J2389/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT92107249T 1991-05-23 1992-04-29 Nichtporöse kollagenfolie zur therapeutischen verwendung, und verfahren und vorrichtung zu ihrer herstellung ATE132517T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911423A IT1249315B (it) 1991-05-23 1991-05-23 Lamina di collageno non poroso per uso terapeutico, metodo ed apparecchiature per ottenerlo

Publications (1)

Publication Number Publication Date
ATE132517T1 true ATE132517T1 (de) 1996-01-15

Family

ID=11359972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92107249T ATE132517T1 (de) 1991-05-23 1992-04-29 Nichtporöse kollagenfolie zur therapeutischen verwendung, und verfahren und vorrichtung zu ihrer herstellung

Country Status (8)

Country Link
EP (1) EP0514691B1 (de)
JP (1) JP3423330B2 (de)
KR (1) KR100229304B1 (de)
CN (1) CN1066790A (de)
AT (1) ATE132517T1 (de)
CA (1) CA2064993C (de)
DE (1) DE69207263T2 (de)
IT (1) IT1249315B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
EP2351557B1 (de) * 2001-10-12 2019-04-17 Aquestive Therapeutics, Inc. Dünner film ohne selbtaggregation mit gleichmässiger heterogenität, verfahren zu deren herstellung, sowie daraus hergestellte arzneistoffabgabesysteme
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7910641B2 (en) 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
WO2006031209A1 (en) * 2003-05-28 2006-03-23 Monosolrx Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
EP1587504B1 (de) * 2003-01-30 2012-04-18 MonoSolRX, LLC Verfahren zur Herstellung eines dünnen Films, thermolabile Wirkstoffe enthaltend
JP4621563B2 (ja) * 2005-08-26 2011-01-26 新田ゼラチン株式会社 皮膚用保水シート
EP2063864A4 (de) 2006-09-20 2012-03-14 Monosol Rx Llc Verzehrbare wasserlösliche folie mit einem schäumungsreduzierenden geschmacksmittel
PT2097116E (pt) 2006-12-22 2012-12-06 Medidom Lab Sistema in situ para reparação de tecido intra-articular condral e ósseo
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
AU2011265294B2 (en) 2010-06-10 2015-01-22 Aquestive Therapeutics, Inc. Nanoparticle film delivery systems
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
CN109364570B (zh) * 2018-12-19 2021-02-02 武汉华星光电半导体显示技术有限公司 一种过滤装置及过滤方法
JP7311983B2 (ja) * 2019-03-01 2023-07-20 大日本印刷株式会社 ゲル膜の製造方法およびゲル膜
EP4422607A4 (de) 2021-10-25 2025-09-03 Aquestive Therapeutics Inc Orale und nasale zusammensetzungen und behandlungsverfahren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1596789A (de) * 1968-11-27 1970-06-22
IT946066B (it) * 1971-11-17 1973-05-21 Sir Soc Italiana Resine Spa Catalizzatori per la produzione dell ossido di etilene per ossi dazione dell etilene
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US4948540A (en) * 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material

Also Published As

Publication number Publication date
EP0514691A2 (de) 1992-11-25
ITMI911423A1 (it) 1992-11-23
IT1249315B (it) 1995-02-22
EP0514691A3 (en) 1993-03-31
EP0514691B1 (de) 1996-01-03
KR920021161A (ko) 1992-12-18
CA2064993A1 (en) 1992-11-24
ITMI911423A0 (it) 1991-05-23
CN1066790A (zh) 1992-12-09
JP3423330B2 (ja) 2003-07-07
CA2064993C (en) 2005-01-18
DE69207263D1 (de) 1996-02-15
DE69207263T2 (de) 1996-05-15
KR100229304B1 (ko) 1999-11-01
JPH05117162A (ja) 1993-05-14

Similar Documents

Publication Publication Date Title
ATE132517T1 (de) Nichtporöse kollagenfolie zur therapeutischen verwendung, und verfahren und vorrichtung zu ihrer herstellung
ATE179632T1 (de) Vorrichtung zum behandeln und übertragen von stoffen zwischen abgeschlossenen räumen
ATA47486A (de) Verfahren zur herstellung von neuen transparenten copolyamiden mischungen daraus, und deren verwendung zur herstellung von formkoerpern
ATE38841T1 (de) Geformter artikel aus hyaluronsaeure und verfahren zu seiner herstellung.
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
IE881638L (en) Hydrophilic acryclic adhesive
DE68913894D1 (de) Verfahren zur Herstellung eines Polymergels, Polymergel und Stellglied, das dieses benutzt.
ATE80010T1 (de) Verfahren zur herstellung von maisfasern mit hohem diaetetischen wert.
DE69533082D1 (de) Ionenleitender Polymerelektrolyt, Verfahren zur Herstellung des Elektrolyts und seine Verwendung in Kondensatoren
DE69202420D1 (de) Vinylalkoholeinheiten enthaltende Polymerfasern mit grosser Feuchtigkeitsabsorption und hoher Wasserabsorption sowie Verfahren zu deren Herstellung.
ATE86115T1 (de) Vorrichtung und verfahren zur herstellung eines komposithautersatzes.
DE59006842D1 (de) Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung.
ATE3866T1 (de) Verfahren zur herstellung einer kollagenloesung, eine solche loesung sowie ihre verwendung.
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE3770465D1 (de) Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.
DE69107031D1 (de) Thexyl-trialkoxysilane, Verfahren zur Herstellung und deren Verwendung.
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
DK1382346T3 (da) Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler
DE3686702D1 (de) Biologisch aktive topische kollagentraegermatrix: kosmetische und pharmazeutische verwendung und verfahren zu deren herstellung.
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
DE3581262D1 (de) Sterilisation eines adsorbens sowie eine saeule mit lagerfaehigkeit die das sterilisierte adsorbens enthaelt zur verwendung in der extrakorporalen blutbehandlung.
DE69029315D1 (de) Verfahren zur Herstellung von Oxazopyrrolochinolinen, die sie enthaltenden Produkte und deren Verwendung
DE3862788D1 (de) Fluessige oxydationsmodifizierte ethylenische statistische copolymere, verfahren zur herstellung und deren verwendung.
DE69119868D1 (de) Verfahren zur Herstellung von Organopolysiloxanen mit einem kontrollierten und niedrigen Gehalt an Hydroxylgruppen
DE3787653D1 (de) Biotechnischer monitor zur kontinuierlichen bestimmung von schadwirkungen auf mikroorganismen in wasser.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties